Revelli J P, Muzzin P, Paoloni A, Moinat M, Giacobino J P
Département de Biochimie Médicale, Centre Médical Universitaire, Geneva, Switzerland.
J Mol Endocrinol. 1993 Apr;10(2):193-7. doi: 10.1677/jme.0.0100193.
The results of this study suggest that the atypical beta-adrenergic receptor (beta 3 subtype) is expressed in human white adipose tissue. A beta 3-adrenergic receptor mRNA could be detected in human omental fat poly(A)+ RNA by polymerase chain reaction amplification with appropriate primers. The expression of the beta 3-adrenergic receptor in human fat was confirmed by Northern blot analysis; however, the level of its mRNA was lower than those of the beta 1- and beta 2-adrenergic receptors. Two populations of ((-)-4-(3-t-butylamino-2-hydroxypropoxy)-[5,7-3H]benzimidazole-2-one) ([3H]CGP 12177)-binding sites were identified in human omental fat membranes, one with a high affinity (Kd = 1.7 nM) and the other with a low affinity (Kd = 22 nM). The low affinity binding site population, which should represent the beta 3-adrenergic receptor, was predominant (75% of the total binding sites).
本研究结果表明,非典型β-肾上腺素能受体(β3亚型)在人类白色脂肪组织中表达。通过使用适当引物进行聚合酶链反应扩增,可在人网膜脂肪poly(A)+ RNA中检测到β3-肾上腺素能受体mRNA。通过Northern印迹分析证实了β3-肾上腺素能受体在人脂肪中的表达;然而,其mRNA水平低于β1-和β2-肾上腺素能受体。在人网膜脂肪膜中鉴定出两类((-)-4-(3-叔丁基氨基-2-羟基丙氧基)-[5,7-3H]苯并咪唑-2-酮)([3H]CGP 12177)结合位点,一类具有高亲和力(Kd = 1.7 nM),另一类具有低亲和力(Kd = 22 nM)。代表β3-肾上腺素能受体的低亲和力结合位点群体占主导(占总结合位点的75%)。